UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 11, 2021

SC Health Corporation
(Exact name of registrant as specified in its charter)

Cayman Islands
001-38972
 N/A
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

108 Robinson Road #10-00
Singapore
  
068900
(Address of principal executive offices)
  
(Zip Code)

+65 6438-1080
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 ☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 
Title of each class
  
Trading Symbol(s)
  
Name of each exchange on which registered
 
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one half of one warrant
   SCPE.U
  
New York Stock Exchange LLC
 
Class A ordinary shares, par value $0.0001 per share
   SCPE  
New York Stock Exchange LLC
 
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
   SCPE WS
  
New York Stock Exchange LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01.
Regulation FD Disclosure.

On August 11, 2021, SC Health Corporation, a Cayman Islands exempted company (the “Company”), and Rockley Photonics Holdings Limited, a Cayman Islands exempted company, jointly issued a press release announcing that they have closed their previously announced business combination. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated by reference herein.

The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended (the “Securities Act”) or the Exchange Act, regardless of any general incorporation language in such filings.

Item 9.01.
Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No.
  
Description
 
Press Release, dated August 11, 2021.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
SC Health Corporation
   
Date: August 13, 2021
By:
/s/ Angelo John Coloma
 
Name:
Angelo John Coloma
 
Title:
Chief Executive Officer